資源描述:
《七葉皂苷鈉治療腦出血的臨床觀察 優(yōu)先出版.pdf》由會員上傳分享,免費在線閱讀,更多相關內(nèi)容在學術論文-天天文庫。
1、網(wǎng)絡出版時間:2017-01-1310:48:16網(wǎng)絡出版地址:http://www.cnki.net/kcms/detail/11.4449.R.20170113.1048.010.html當代醫(yī)學2017年2月第23卷第04期總第447期ContemporaryMedicine,F(xiàn)eb.2017,Vol.23No.04IssueNo.447doi:10.3969/j.issn.1009-4393.2017.04.005--論著--七葉皂苷鈉治療腦出血的臨床觀察倪洪巖,姜靜,孫美波(遼寧省大連莊河市中心醫(yī)院神經(jīng)內(nèi)一科,遼
2、寧大連116400)摘要:目的探究七葉皂苷鈉治療腦出血的臨床治療效果。方法選取80例因腦出血入院治療患者,按病床單雙號分為聯(lián)合組40例、單一組40例。單一組采用依達拉奉,聯(lián)合組在此基礎上加用七葉皂苷鈉,觀察兩組患者腦出血、腦水腫情況,神經(jīng)功能恢復情況,并根據(jù)綜合指標判斷療效,統(tǒng)計用藥期間不良反應情況。結果聯(lián)合組總有效率高達95.0%,單一組為80.0%,單一組較聯(lián)合組療效差,差異有統(tǒng)計學意義(c2=4.114,P<0.05);未治療時兩組腦血腫、腦水腫、神經(jīng)功能缺損程度比較差異無統(tǒng)計學意義,治療后聯(lián)合組神經(jīng)功能、腦血腫、腦
3、水腫分別為(4.74±2.67)、(12.62±4.27)、(9.15±3.15),單一組依次為(10.35±2.72)、(17.73±5.25)、(13.36±4.47);聯(lián)合組較單一組患者腦血腫、神經(jīng)功能缺損明顯好轉,腦水腫明顯控制,差異有統(tǒng)計學意義(t=9.309,t=4.776,t=4.869,P<0.05)。結論臨床對腦出血患者進行治療時,為提高治療效果加快患者恢復,改善患者神經(jīng)功能缺損、促進血腫吸收、控制水腫擴散,可使用依達拉奉與七葉皂苷鈉聯(lián)合治療。關鍵詞:療效;安全性;腦出血;依達拉奉;七葉皂苷鈉Clinic
4、alobservationofSodiumAescinateinthetreatmentofcerebralhemorrhageNiHong-yan,JiangJing,SunMei-bo(NeurologyDepartmentIOfZhuangheCentralHospitalOfDalianCity,Dalian,Liaoning,116400,China)Abstract:ObjectiveToobservetheclinicaleffectofSodiumAescinate.Methods80patientswit
5、hcerebralhemorrhageinourhospitalwereselected.Thesubjectsweredividedintotwogroupsaccordingtotheoddorevennumberofhospitalbed,40caseseachgroup.ThesinglegrouptooktheEdaravoneInjection;onthebasis,thecombinedgrouptooktheSodiumAescinateInjection.Theevaluationscoreofcereb
6、ralhemorrhageandcerebraledema,recoveryofneurologicalfunction,clinicaleffectaswellasadversereactionsfortwogroupswereobserved.ResultsThetotaleffectiverateofcombinedgroup(95.0%)washigherthansinglegroup(85.0%)(c2=5.556,P<0.05);beforetreatment,theevaluationscoreofcereb
7、ralhemorrhage,cerebraledemaandneurologicalde-fectsfortwogroupswasnotsignificantlydifferent.Aftertreatment,theevaluationscoreofcerebralhemorrhage,cerebraledemaandneurologicaldefectsforcombinedgroupwas(4.74±2.67),(12.62±4.27)and(9.15±3.15);theevaluationscoreforsingl
8、egroupwas(10.35±2.72),(17.73±5.25)and(13.36±4.47);theimprovementofcerebralhemorrhageandneurologicaldefectsforcombinedgroupwasbetterthansinglegroup;thece